Sign in

Matthew Brees

Vice President and Equity Research Analyst at Barclays PLC

Matthew Brees is a Vice President and Equity Research Analyst at Barclays, specializing in consumer and retail sector coverage with a focus on companies including Walmart, Target, Dollar General, and Costco. He is recognized for delivering in-depth investment insights and earnings analyses, and his research has contributed to actionable recommendations for institutional clients. Brees began his career as an analyst at a boutique advisory firm before joining Barclays in 2019, where he has steadily advanced to his current leadership role. He holds a CFA designation and is registered with FINRA, holding Series 7, 63, and 86/87 securities licenses.

Matthew Brees's questions to FLAGSTAR BANK, NATIONAL ASSOCIATION (FLG) leadership

Question · Q3 2025

Matthew Brees from Barclays asked about the percentage of Flagstar Bank N.A.'s loans that are pure floating rate and the spot cost of deposits at quarter-end or currently. He also inquired about the reason for the change in the tangible book value outlook to include warrants, the expectations for average diluted versus common shares outstanding for Q4 2025 and early 2026, and whether the expectation of profitability in Q4 2025 still holds.

Answer

CFO Lee Smith explained that C&I loans are floating rate, and residential loans are typically 5, 7, or 10-year ARMs. He stated the spot cost of deposits was 2.82% a couple of days prior. The change in tangible book value outlook and share count (from 416 million to 480 million) is due to warrants kicking in during Q4 2025, impacting both diluted and common shares outstanding through 2026 and 2027. Lee Smith reiterated the expectation for profitability in Q4 2025, citing the progress made over recent quarters.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts